HealthcarePolicy
China Expands Drug Procurement with 65 New Medicines
China's 12th national drug procurement adds 65 medicines, covering 555 total, expanding affordable access to chronic disease and critical care treatments.
—4 min read
Tag
4 articles
China's 12th national drug procurement adds 65 medicines, covering 555 total, expanding affordable access to chronic disease and critical care treatments.
China's 12th national drug procurement round adds 65 medicines, easing patient costs while introducing new rules to curb extreme price cuts.
China's NHSA reveals a drug company forged 80% of doctor signatures in a letter to influence drug procurement. Novartis and Takeda deny involvement.
China's 12th drug procurement round shifts focus to clinical value, with anti-involution measures and a revival mechanism for originator drugs.